Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pediatric ponatinib study in recurrent or refractory leukemias or solid tumors
NL-OMON54589Phase 2Recruiting
- Sponsor
- Incyte
- Start
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ponatinib in chronic myelogenous leukemia (CML), acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), leukemia, lymphoma, sponsored by Incyte. Started Jun 2020; status: recruiting.
02
Drugs
ponatinib
03
Conditions
chronic myelogenous leukemia (CML)acute lymphoblastic leukemia (ALL)acute myeloid leukemia (AML)leukemialymphoma
Beyond the preview
Go deeper on NL-OMON54589.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON54589.